Data Analysis Simplified | Book Your Demo with CellCarta
It’s easy to analyze cytometry data with CellCarta. Discover the software our experts use to get the job done right.
Watch the CellEngine Demo:
Our team of experts harness the potential of multiparametric flow cytometry. We work with you to deliver both qualitative and quantitative analyses of samples using a wide range of high throughput and multiplexing instruments – including spectral flow!
Our flow cytometry platforms are in North America, Europe, China, and Australia, which allows us to support flow cytometry assays for global trials. All sites are equipped with the latest technology in the field.
Identify, quantify, and monitor your cell population of interest as well as its functional activity using off-the-shelf or highly customized panels. Our scientists are experts in both flow cytometry and immunology. They can guide you towards the right panels, so you get the most insight out of your samples.
CellEngine®: A New Generation of Cytometry Software
Our immunologists collaborated with our bioinformatics team to design CellEngine® – a cytometry software adapted to your needs:
Cloud-based for easy collaboration
Blasting fast analysis
Advanced visualization
Advanced API – with potential LIMS integration
Metadata-driven analysis
21 CFR 11 compliant
Learn more about the power of CellEngine and its automation tools in a recent article by our expert!
Data Analysis Simplified | Book Your Demo with CellCarta
It’s easy to analyze cytometry data with CellCarta. Discover the software our experts use to get the job done right.
Watch the CellEngine Demo:
Our team of experts harness the potential of multiparametric flow cytometry. We work with you to deliver both qualitative and quantitative analyses of samples using a wide range of high throughput and multiplexing instruments – including spectral flow!
Our flow cytometry platforms are in North America, Europe, China, and Australia, which allows us to support flow cytometry assays for global trials. All sites are equipped with the latest technology in the field.
Identify, quantify, and monitor your cell population of interest as well as its functional activity using off-the-shelf or highly customized panels. Our scientists are experts in both flow cytometry and immunology. They can guide you towards the right panels, so you get the most insight out of your samples.
CellEngine®: A New Generation of Cytometry Software
Our immunologists collaborated with our bioinformatics team to design CellEngine® – a cytometry software adapted to your needs:
Cloud-based for easy collaboration
Blasting fast analysis
Advanced visualization
Advanced API – with potential LIMS integration
Metadata-driven analysis
21 CFR 11 compliant
Learn more about the power of CellEngine and its automation tools in a recent article by our expert!
Global Sample Processing for Clinical Trials
May 1, 2024
High-Quality Sample Processing by CellCarta for Clinical Trials
In the rapidly evolving landscape of clinical research, the integrity and quality of biological samples are paramount. CellCarta’s Global Sample Processing Network is designed to support the complex needs of modern clinical trials by providing comprehensive sample processing services.
Our network ensures consistent, high-quality data through rigorous standardization and state-of-the-art technology, making us a trusted CRO partner for researchers worldwide seeking reliable clinical trial support.
CellCarta’s Comprehensive Service Overview
PBMC Processing Services
At CellCarta, we specialize in the isolation and cryopreservation of Peripheral Blood Mononuclear Cells (PBMCs). Utilizing both methodologies (Ficoll and CPT tube separation), we maintain high cell viability and recovery rates.
Our globally harmonized Standard Operating Procedures (SOPs) ensure that every sample is processed to the highest standards, irrespective of its origin. This meticulous approach minimizes variability, providing reliable processed samples for downstream applications like biomarker analysis by flow cytometry, and further immune monitoring.
Global Logistics and Sample Solutions
Our logistics network is optimized for the safe and efficient transport of clinical samples. We monitor samples and ensure integrity during transport. Our rapid turnaround time (TAT) is a critical feature, ensuring timely data for your clinical trials.
We operate as a global CRO logistics provider, with end-to-end handling and secure tracking of specimens from clinic to lab. Our real-time tracking and global footprint are key elements for global clinical programs, ensuring we maintain high quality of clinical samples.
Specialized Capabilities
Our laboratories are equipped to handle various sample types, including frozen tissue and FFPE blocks. We offer bespoke services, such as the normalization of cell numbers and the use of specialized freezing media, to meet the unique requirements of your research.
These capabilities, along with advanced logistics for multi-center trials make CellCarta the CRO logistics partner of choice for your oncology, immunology, infectious diseases, and ADC development programs.
Case Studies and Client Testimonials
Our success stories speak volumes about our capabilities. From supporting large-scale immuno-oncology trials to providing specialized PBMC processing for smaller studies, CellCarta has been at the forefront of advancing scientific research.
Clients consistently commend our reliability, expertise, and commitment to quality, making us their preferred sample analysis CRO partner.
Global Reach and Expertise
With a network spanning multiple continents, CellCarta ensures that high-quality sample processing services are accessible globally. Our strategically located laboratories and partnerships with local facilities enable us to provide consistent services worldwide.
Our team of highly trained professionals adheres to global standards, ensuring uniformity and precision in every sample processed. As a specialized CRO with global infrastructure, we’re equipped to manage complex sample pipelines across clinical sites in North America, Europe, Asia and Australia.
Quality Assurance and Compliance
Quality is at the core of our operations. We employ a comprehensive quality control program that includes regular proficiency testing and real-time monitoring of processing metrics. Our facilities comply with international standards, and we hold various certifications that underscore our commitment to excellence.
Why Choose CellCarta?
At CellCarta, we understand that every sample is crucial. Our dedication to maintaining high standards, combined with our innovative solutions and global reach, sets us apart as a leader in the field of sample processing.
Partner with CellCarta, a global CRO trusted by biopharma leaders to ensure sample quality, data integrity, and operational efficiency at every step of your clinical trial journey.
Global Sample Processing for Clinical Trials
May 1, 2024
High-Quality Sample Processing by CellCarta for Clinical Trials
In the rapidly evolving landscape of clinical research, the integrity and quality of biological samples are paramount. CellCarta’s Global Sample Processing Network is designed to support the complex needs of modern clinical trials by providing comprehensive sample processing services.
Our network ensures consistent, high-quality data through rigorous standardization and state-of-the-art technology, making us a trusted CRO partner for researchers worldwide seeking reliable clinical trial support.
CellCarta’s Comprehensive Service Overview
PBMC Processing Services
At CellCarta, we specialize in the isolation and cryopreservation of Peripheral Blood Mononuclear Cells (PBMCs). Utilizing both methodologies (Ficoll and CPT tube separation), we maintain high cell viability and recovery rates.
Our globally harmonized Standard Operating Procedures (SOPs) ensure that every sample is processed to the highest standards, irrespective of its origin. This meticulous approach minimizes variability, providing reliable processed samples for downstream applications like biomarker analysis by flow cytometry, and further immune monitoring.
Global Logistics and Sample Solutions
Our logistics network is optimized for the safe and efficient transport of clinical samples. We monitor samples and ensure integrity during transport. Our rapid turnaround time (TAT) is a critical feature, ensuring timely data for your clinical trials.
We operate as a global CRO logistics provider, with end-to-end handling and secure tracking of specimens from clinic to lab. Our real-time tracking and global footprint are key elements for global clinical programs, ensuring we maintain high quality of clinical samples.
Specialized Capabilities
Our laboratories are equipped to handle various sample types, including frozen tissue and FFPE blocks. We offer bespoke services, such as the normalization of cell numbers and the use of specialized freezing media, to meet the unique requirements of your research.
These capabilities, along with advanced logistics for multi-center trials make CellCarta the CRO logistics partner of choice for your oncology, immunology, infectious diseases, and ADC development programs.
Case Studies and Client Testimonials
Our success stories speak volumes about our capabilities. From supporting large-scale immuno-oncology trials to providing specialized PBMC processing for smaller studies, CellCarta has been at the forefront of advancing scientific research.
Clients consistently commend our reliability, expertise, and commitment to quality, making us their preferred sample analysis CRO partner.
Global Reach and Expertise
With a network spanning multiple continents, CellCarta ensures that high-quality sample processing services are accessible globally. Our strategically located laboratories and partnerships with local facilities enable us to provide consistent services worldwide.
Our team of highly trained professionals adheres to global standards, ensuring uniformity and precision in every sample processed. As a specialized CRO with global infrastructure, we’re equipped to manage complex sample pipelines across clinical sites in North America, Europe, Asia and Australia.
Quality Assurance and Compliance
Quality is at the core of our operations. We employ a comprehensive quality control program that includes regular proficiency testing and real-time monitoring of processing metrics. Our facilities comply with international standards, and we hold various certifications that underscore our commitment to excellence.
Why Choose CellCarta?
At CellCarta, we understand that every sample is crucial. Our dedication to maintaining high standards, combined with our innovative solutions and global reach, sets us apart as a leader in the field of sample processing.
Partner with CellCarta, a global CRO trusted by biopharma leaders to ensure sample quality, data integrity, and operational efficiency at every step of your clinical trial journey.
Comprehensive Histology and Pathology Services by CellCarta
November 22, 2022
Explore Our Advanced Histopathology Laboratories!
As a leading contract research organization (CRO), we offer a wide array of histopathology services.
Our histopathology facilities have trained in-house pathologists and multiple platforms to partner with you and provide integrated solutions for your specific clinical trial needs.
We deliver preclinical and clinical histology support to pharmaceutical and biotech sponsors worldwide.
Discover how CellCarta advances histopathology research and services.
We offer testing services for all phases of clinical trials including:
As a CAP/CLIA-certified CRO Lab, we support clinical studies for diagnostic and pharmaceutical partners in preparation for FDA, EU, and other global submissions.
Our digital pathology services and AI powered workflows provide scalable solutions for high-throughput histology testing across disease areas.
Histology CRO and Pathology CRO Services
Building on our comprehensive services, CellCarta’s Histology CRO capabilities extend to custom assay development and validation, supporting a wide range of clinical and research applications.
Our expert team provides histology support for CROs, offering tailored solutions to meet the specific requirements of each study. This includes detailed consultation on sample preparation, staining protocols, and data interpretation.
We offers both off-the-shelf and customized routine and advanced digital histology services, with an expert team ensuring reproducibility, scalability, and regulatory readiness.
Advanced Molecular and Digital Pathology Services
In addition to our core services, we provide advanced molecular pathology services, including in situ hybridization (ISH) and fluorescence in situ hybridization (FISH).
These techniques enable the detection of specific biomarkers and genetic materials within tissue samples, aiding in the identification and characterization of diseases.
Our digital pathology platforms, featuring whole slide imaging and automated image analysis, allows for accurate, reproducible data generation and efficient workflow management.
Collaborations and Software Solutions
We collaborate with industry leaders to enhance our service offerings and stay at the forefront of histopathology innovations.
Our histopathology software, including advanced AI-driven platforms, streamline data analysis and provide deeper insights into your samples.
This integration of cutting-edge technology ensures that our clients receive the most reliable and insightful data possible, ensuring CellCarta provides top CRO pathology services for your oncology, immunology, and biomarker programs regardless of disease area.
Quality Assurance and Global Compliance
Our commitment to quality goes beyond our technical capabilities. As a CAP/CLIA certified lab, we adhere to stringent quality control measures and global standards.
This ensures that our data and analyses are robust, reproducible, and ready for regulatory submissions worldwide, including FDA and EU approvals.
Our comprehensive quality assurance program includes regular proficiency testing and adherence to best practices in laboratory operations.
Why Choose CellCarta?
CellCarta offers unparalleled expertise in histopathology CRO services, making us a trusted partner for pharmaceutical companies and research institutions.
Whether you require IHC CRO services, digital pathology support, or full-service histopathology assay development, our team is equipped to deliver high-quality data.
Our comprehensive range of services, from routine histology to advanced molecular analyses, combined with our commitment to quality and innovation, ensures that we deliver accurate, high-quality data tailored to your specific needs.
Comprehensive Histology and Pathology Services by CellCarta
November 22, 2022
Explore Our Advanced Histopathology Laboratories!
As a leading contract research organization (CRO), we offer a wide array of histopathology services.
Our histopathology facilities have trained in-house pathologists and multiple platforms to partner with you and provide integrated solutions for your specific clinical trial needs.
We deliver preclinical and clinical histology support to pharmaceutical and biotech sponsors worldwide.
Discover how CellCarta advances histopathology research and services.
We offer testing services for all phases of clinical trials including:
As a CAP/CLIA-certified CRO Lab, we support clinical studies for diagnostic and pharmaceutical partners in preparation for FDA, EU, and other global submissions.
Our digital pathology services and AI powered workflows provide scalable solutions for high-throughput histology testing across disease areas.
Histology CRO and Pathology CRO Services
Building on our comprehensive services, CellCarta’s Histology CRO capabilities extend to custom assay development and validation, supporting a wide range of clinical and research applications.
Our expert team provides histology support for CROs, offering tailored solutions to meet the specific requirements of each study. This includes detailed consultation on sample preparation, staining protocols, and data interpretation.
We offers both off-the-shelf and customized routine and advanced digital histology services, with an expert team ensuring reproducibility, scalability, and regulatory readiness.
Advanced Molecular and Digital Pathology Services
In addition to our core services, we provide advanced molecular pathology services, including in situ hybridization (ISH) and fluorescence in situ hybridization (FISH).
These techniques enable the detection of specific biomarkers and genetic materials within tissue samples, aiding in the identification and characterization of diseases.
Our digital pathology platforms, featuring whole slide imaging and automated image analysis, allows for accurate, reproducible data generation and efficient workflow management.
Collaborations and Software Solutions
We collaborate with industry leaders to enhance our service offerings and stay at the forefront of histopathology innovations.
Our histopathology software, including advanced AI-driven platforms, streamline data analysis and provide deeper insights into your samples.
This integration of cutting-edge technology ensures that our clients receive the most reliable and insightful data possible, ensuring CellCarta provides top CRO pathology services for your oncology, immunology, and biomarker programs regardless of disease area.
Quality Assurance and Global Compliance
Our commitment to quality goes beyond our technical capabilities. As a CAP/CLIA certified lab, we adhere to stringent quality control measures and global standards.
This ensures that our data and analyses are robust, reproducible, and ready for regulatory submissions worldwide, including FDA and EU approvals.
Our comprehensive quality assurance program includes regular proficiency testing and adherence to best practices in laboratory operations.
Why Choose CellCarta?
CellCarta offers unparalleled expertise in histopathology CRO services, making us a trusted partner for pharmaceutical companies and research institutions.
Whether you require IHC CRO services, digital pathology support, or full-service histopathology assay development, our team is equipped to deliver high-quality data.
Our comprehensive range of services, from routine histology to advanced molecular analyses, combined with our commitment to quality and innovation, ensures that we deliver accurate, high-quality data tailored to your specific needs.
CellCarta Naperville Lab | Genomic and Histopathology Services
October 12, 2022
Step Into Our Naperville Facility!
In 2022, we proudly announced the grand opening of our Naperville, Chicago location!
Our new facility is only 30 minutes from the Chicago O’Hare airport and encompasses over 3,000m2 (29,283 sq ft) of innovative scientific equipment and highly trained staff.
As part of CellCarta’s global CRO infrastructure, this lab strengthens our clinical trial support capabilities across North America.
Join us for a tour and see how CellCarta is dedicated to advancing scientific research.
At Naperville, we offer testing services for all phases of clinical trials. As a CRO with multiomics capabilities, we support:
Our Naperville facility is designed to provide comprehensive testing services across various phases of clinical trials. Our advanced genomic capabilities include-
These techniques are essential for precise genetic analysis and biomarker discovery, aiding in the development of targeted therapies and personalized medicine.
We support both preclinical and clinical studies across oncology and immunology, as well as specialized therapeutic development such as ADC programs.
Software platforms include: Indica Labs’ HALO®, Visiopharm®, Akoya’s inForm®, CyteHub®, SoloWeb, and navify® by Roche.
As a CAP/CLIA certified lab, we support clinical studies for diagnostic and pharmaceutical partners in preparation for FDA, EU and other global submissions.
Our histology CRO services are integrated into our multiomic CRO offerings, enabling scalable analysis pipelines for high-volume biomarker testing across platforms and therapeutic areas.
We support both preclinical and clinical studies across oncology, immunology, and more, with specialized support for ADC development programs.
Commitment to Quality and Compliance
As a CAP accredited and CLIA certified laboratory, we adhere to the highest standards of quality and compliance.
Our rigorous quality control measures ensure the reliability and accuracy of our data, supporting clinical studies for regulatory submissions worldwide, including FDA and EU approvals.
Our quality management system (QMS) drives harmonization of specific testing services and related activities and is implemented at all levels of the organization.
Strategic Location and Accessibility
Located just 30 minutes from Chicago O’Hare airport, our Naperville facility is easily accessible for local and international clients. The facility spans over 3,000m² (29,283 sq ft) and is equipped with the latest scientific equipment, operated by a team of highly trained professionals dedicated to advancing scientific research.
Why Choose CellCarta?
CellCarta is committed to delivering high-quality, reliable data through our extensive range of testing services and advanced technologies. Our new Naperville facility exemplifies our dedication to supporting clinical trials and research initiatives with state-of-the-art resources and expert staff.
As a global CRO, our Naperville site provides key clinical trial services in genomics, histopathology, and biomarker programs.
Backed by our expert scientific teams and cutting-edge platforms, we help biopharma clients accelerate drug development with data they can trust.
CellCarta Naperville Lab | Genomic and Histopathology Services
October 12, 2022
Step Into Our Naperville Facility!
In 2022, we proudly announced the grand opening of our Naperville, Chicago location!
Our new facility is only 30 minutes from the Chicago O’Hare airport and encompasses over 3,000m2 (29,283 sq ft) of innovative scientific equipment and highly trained staff.
As part of CellCarta’s global CRO infrastructure, this lab strengthens our clinical trial support capabilities across North America.
Join us for a tour and see how CellCarta is dedicated to advancing scientific research.
At Naperville, we offer testing services for all phases of clinical trials. As a CRO with multiomics capabilities, we support:
Our Naperville facility is designed to provide comprehensive testing services across various phases of clinical trials. Our advanced genomic capabilities include-
These techniques are essential for precise genetic analysis and biomarker discovery, aiding in the development of targeted therapies and personalized medicine.
We support both preclinical and clinical studies across oncology and immunology, as well as specialized therapeutic development such as ADC programs.
Software platforms include: Indica Labs’ HALO®, Visiopharm®, Akoya’s inForm®, CyteHub®, SoloWeb, and navify® by Roche.
As a CAP/CLIA certified lab, we support clinical studies for diagnostic and pharmaceutical partners in preparation for FDA, EU and other global submissions.
Our histology CRO services are integrated into our multiomic CRO offerings, enabling scalable analysis pipelines for high-volume biomarker testing across platforms and therapeutic areas.
We support both preclinical and clinical studies across oncology, immunology, and more, with specialized support for ADC development programs.
Commitment to Quality and Compliance
As a CAP accredited and CLIA certified laboratory, we adhere to the highest standards of quality and compliance.
Our rigorous quality control measures ensure the reliability and accuracy of our data, supporting clinical studies for regulatory submissions worldwide, including FDA and EU approvals.
Our quality management system (QMS) drives harmonization of specific testing services and related activities and is implemented at all levels of the organization.
Strategic Location and Accessibility
Located just 30 minutes from Chicago O’Hare airport, our Naperville facility is easily accessible for local and international clients. The facility spans over 3,000m² (29,283 sq ft) and is equipped with the latest scientific equipment, operated by a team of highly trained professionals dedicated to advancing scientific research.
Why Choose CellCarta?
CellCarta is committed to delivering high-quality, reliable data through our extensive range of testing services and advanced technologies. Our new Naperville facility exemplifies our dedication to supporting clinical trials and research initiatives with state-of-the-art resources and expert staff.
As a global CRO, our Naperville site provides key clinical trial services in genomics, histopathology, and biomarker programs.
Backed by our expert scientific teams and cutting-edge platforms, we help biopharma clients accelerate drug development with data they can trust.